Neuron-specific expression of Tau in tauopathy models affects the nervous system, resulting in morphological and functional defects at multiple levels, and the locomotion phenotype is an essential assay that allows evaluation of those defects collectively. The gene discussed is MAPT; the disease is tauopathy.